Predicting progression in nondiabetic kidney disease: The importance of cardiorenal interactions

Kidney International

Volumn 75, Issue 3, 2009, Pages 253-255

  Breidthardt, Tobias ^a   Mebazaa, Alexandre ^a   Mueller, Christian E ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIORENAL SYNDROME; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HEART; HEART DISEASE; HUMAN; KIDNEY; KIDNEY FAILURE; NOTE; PRIORITY JOURNAL; PROGNOSIS;

EID: 58349093587     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.591     Document Type: Note

References (10)

1. O'Hare AM, Bertenthal D, Walter LC et al. When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007; 71: 555-561.
2. Dieplinger B, Mueller T, Kollerits B et al. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney Int 2009; 75: xxx-xxx.
3. Cheung BM, Li CY, Wong LY. Adrenomedullin: its role in the cardiovascular system. Semin Vasc Med 2004; 4: 129-134.
4. Yoshihara F, Ernst A, Morgenthaler NG et al. Midregional proadrenomedullin reflects cardiac dysfunction in haemodialysis patients with cardiovascular disease. Nephrol Dial Transplant 2007; 22: 2263-2268.
5. Yoshihara F, Nishikimi T, Horio T et al. Ventricular adrenomedullin concentration is a sensitive biochemical marker for volume and pressure overload in rats. Am J Physiol Heart Circ Physiol 2000; 278: H633-H642.
6. Chun TH, Itoh H, Ogawa Y et al. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997; 29: 1296-1302.
7. Berl T, Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 2006; 1: 8-18.
8. Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 2008; 34: 957-962.
9. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003; 42: 201-208.
10. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160: 685-693.